UPDATE: AdaptHealth Corp. (AHCO) Misses Q3 EPS by 16c, Revenue Beats, Updates Guidance
AdaptHealth Corp. (NASDAQ: AHCO) reported Q3 EPS of ($0.04), $0.16 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $284.4 million versus the consensus estimate of $265.31 million.
Increased Guidance:
While it is difficult to predict the duration of the COVID-19 crisis, based on current business and market trends, the Company is increasing financial guidance for fiscal year 2020 for net revenue to $1.00 billion to $1.04 billion, Adjusted EBITDA to $186 million to $194 million, and Adjusted EBITDA less Patient Equipment Capex to $124 million to $130 million.
For 2021, the Company is guiding net revenue of $1.30 billion to $1.40 billion, Adjusted EBITDA of $260 million to $280 million and Adjusted EBITDA less Patient Equipment Capex of $180 million to $200 million.
For earnings history and earnings-related data on AdaptHealth Corp. (AHCO) click here.